 | • レポートコード：QYR9ST07255 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥828,800 (USD5,600) | ▷ お問い合わせ |
| Enterprise License | ￥1,657,600 (USD11,200) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の双極性障害治療薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。双極性障害治療薬の種類別には、オランザピン（ジプレキサ）、クエチアピン（セロクエル）、リスペリドン（リスパーダル）、アリプラゾール（アビリファイ）、ジプラシドン（ジオドン）、クロザピン（クロザリル）に、用途別には、ルマテペロン、中枢神経系（CNS）障害に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・双極性障害治療薬の種類別市場規模：オランザピン（ジプレキサ）、クエチアピン（セロクエル）、リスペリドン（リスパーダル）、アリプラゾール（アビリファイ）、ジプラシドン（ジオドン）、クロザピン（クロザリル） ・双極性障害治療薬の用途別市場規模：ルマテペロン、中枢神経系（CNS）障害 ・双極性障害治療薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：AstraZeneca、Allergan、Bristol-Myers Squibb、GSK、Janssen、AbbVie、Youdim、Delpor、Lundbeck、Intra-Cellular Therapies、Novartis Pharmaceuticals Corporation、Noven Pharmaceuticals、Otsuka、Pfizer、Reviva Pharmaceuticals ・市場規模予測2019-2025：生産量 ・市場規模予測2019-2025：消費量 ・バリューチェーン・販売チャネル分析 ・市場機会・課題分析 ... |
Bipolar disorder, also known as manic-depressive disorder, is a combination of manic, hypomanic and depressive episodes.The ultimate goal of therapeutic agents for bipolar disorder is to improve patients’ quality of life and maintain good social function as much as possible.The Bipolar Disorder Therapeutics Drugs market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Bipolar Disorder Therapeutics Drugs.
This study focuses on the production side and consumption side of Bipolar Disorder Therapeutics Drugs, presents the global Bipolar Disorder Therapeutics Drugs market size by manufacturers, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
In terms of production side, this report researches the Bipolar Disorder Therapeutics Drugs capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.
In terms of consumption side, this report focuses on the consumption of Bipolar Disorder Therapeutics Drugs by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.
This report includes the following manufacturers; we can also add the other companies as you want.
AstraZeneca
Allergan
Bristol-Myers Squibb
GSK
Janssen
AbbVie
Youdim
Delpor
Lundbeck
Intra-Cellular Therapies
Novartis Pharmaceuticals Corporation
Noven Pharmaceuticals
Otsuka
Pfizer
Reviva Pharmaceuticals
Market Segment by Product Type
Olanzapine (Zyprexa)
Quetiapine (Seroquel)
Risperidone (Risperdal)
Ariprazole (Abilify)
Ziprasidone (Geodon)
Clozapine (Clozaril)
Market Segment by Application
lumateperone
Central Nervous System (CNS) Disorders
Key Regions split in this report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives are:
To analyze and research the global Bipolar Disorder Therapeutics Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Bipolar Disorder Therapeutics Drugs manufacturers, capacity, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Bipolar Disorder Therapeutics Drugs are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Type
1.3.2 Olanzapine (Zyprexa)
1.3.3 Quetiapine (Seroquel)
1.3.4 Risperidone (Risperdal)
1.3.5 Ariprazole (Abilify)
1.3.6 Ziprasidone (Geodon)
1.3.7 Clozapine (Clozaril)
1.4 Market Segment by Application
1.4.1 Global Bipolar Disorder Therapeutics Drugs Market Share by Application (2019-2025)
1.4.2 lumateperone
1.4.3 Central Nervous System (CNS) Disorders
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Bipolar Disorder Therapeutics Drugs Production Value 2014-2025
2.1.2 Global Bipolar Disorder Therapeutics Drugs Production 2014-2025
2.1.3 Global Bipolar Disorder Therapeutics Drugs Capacity 2014-2025
2.1.4 Global Bipolar Disorder Therapeutics Drugs Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Bipolar Disorder Therapeutics Drugs Market Size CAGR of Key Regions
2.2.2 Global Bipolar Disorder Therapeutics Drugs Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Bipolar Disorder Therapeutics Drugs Capacity by Manufacturers
3.1.2 Global Bipolar Disorder Therapeutics Drugs Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Bipolar Disorder Therapeutics Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Bipolar Disorder Therapeutics Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Bipolar Disorder Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Bipolar Disorder Therapeutics Drugs Price by Manufacturers
3.4 Key Manufacturers Bipolar Disorder Therapeutics Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Bipolar Disorder Therapeutics Drugs Market
3.6 Key Manufacturers Bipolar Disorder Therapeutics Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Olanzapine (Zyprexa) Production and Production Value (2014-2019)
4.1.2 Quetiapine (Seroquel) Production and Production Value (2014-2019)
4.1.3 Risperidone (Risperdal) Production and Production Value (2014-2019)
4.1.4 Ariprazole (Abilify) Production and Production Value (2014-2019)
4.1.5 Ziprasidone (Geodon) Production and Production Value (2014-2019)
4.1.6 Clozapine (Clozaril) Production and Production Value (2014-2019)
4.2 Global Bipolar Disorder Therapeutics Drugs Production Market Share by Type
4.3 Global Bipolar Disorder Therapeutics Drugs Production Value Market Share by Type
4.4 Bipolar Disorder Therapeutics Drugs Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Bipolar Disorder Therapeutics Drugs Consumption by Application
6 Production by Regions
6.1 Global Bipolar Disorder Therapeutics Drugs Production (History Data) by Regions 2014-2019
6.2 Global Bipolar Disorder Therapeutics Drugs Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Bipolar Disorder Therapeutics Drugs Production Growth Rate 2014-2019
6.3.2 United States Bipolar Disorder Therapeutics Drugs Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Bipolar Disorder Therapeutics Drugs Import & Export
6.4 Europe
6.4.1 Europe Bipolar Disorder Therapeutics Drugs Production Growth Rate 2014-2019
6.4.2 Europe Bipolar Disorder Therapeutics Drugs Production Value Growth Rate 2014-2019
6.4.3 Key Players in Europe
6.4.4 Europe Bipolar Disorder Therapeutics Drugs Import & Export
6.5 China
6.5.1 China Bipolar Disorder Therapeutics Drugs Production Growth Rate 2014-2019
6.5.2 China Bipolar Disorder Therapeutics Drugs Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Bipolar Disorder Therapeutics Drugs Import & Export
6.6 Japan
6.6.1 Japan Bipolar Disorder Therapeutics Drugs Production Growth Rate 2014-2019
6.6.2 Japan Bipolar Disorder Therapeutics Drugs Production Value Growth Rate 2014-2019
6.6.3 Key Players in Japan
6.6.4 Japan Bipolar Disorder Therapeutics Drugs Import & Export
6.7 Other Regions
6.7.1 South Korea
6.7.2 India
6.7.3 Southeast Asia
7 Bipolar Disorder Therapeutics Drugs Consumption by Regions
7.1 Global Bipolar Disorder Therapeutics Drugs Consumption (History Data) by Regions
7.2 North America
7.2.1 North America Bipolar Disorder Therapeutics Drugs Consumption by Type
7.2.2 North America Bipolar Disorder Therapeutics Drugs Consumption by Application
7.2.3 North America Bipolar Disorder Therapeutics Drugs Consumption by Countries
7.2.4 United States
7.2.5 Canada
7.2.6 Mexico
7.3 Europe
7.3.1 Europe Bipolar Disorder Therapeutics Drugs Consumption by Type
7.3.2 Europe Bipolar Disorder Therapeutics Drugs Consumption by Application
7.3.3 Europe Bipolar Disorder Therapeutics Drugs Consumption by Countries
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
7.4 Asia Pacific
7.4.1 Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption by Type
7.4.2 Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption by Application
7.4.3 Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption by Regions
7.4.4 China
7.4.5 Japan
7.4.6 South Korea
7.4.7 India
7.4.8 Australia
7.4.9 Indonesia
7.4.10 Thailand
7.4.11 Malaysia
7.4.12 Philippines
7.4.13 Vietnam
7.5 Central & South America
7.5.1 Central & South America Bipolar Disorder Therapeutics Drugs Consumption by Type
7.5.2 Central & South America Bipolar Disorder Therapeutics Drugs Consumption by Application
7.5.3 Central & South America Bipolar Disorder Therapeutics Drugs Consumption by Countries
7.5.4 Brazil
7.6 Middle East and Africa
7.6.1 Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption by Type
7.6.2 Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption by Application
7.6.3 Central & South America Bipolar Disorder Therapeutics Drugs Consumption by Countries
7.6.4 Turkey
7.6.5 GCC Countries
7.6.6 Egypt
7.6.7 South Africa
8 Company Profiles
8.1 AstraZeneca
8.1.1 AstraZeneca Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Bipolar Disorder Therapeutics Drugs
8.1.4 Bipolar Disorder Therapeutics Drugs Product Introduction
8.1.5 AstraZeneca Recent Development
8.2 Allergan
8.2.1 Allergan Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Bipolar Disorder Therapeutics Drugs
8.2.4 Bipolar Disorder Therapeutics Drugs Product Introduction
8.2.5 Allergan Recent Development
8.3 Bristol-Myers Squibb
8.3.1 Bristol-Myers Squibb Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Bipolar Disorder Therapeutics Drugs
8.3.4 Bipolar Disorder Therapeutics Drugs Product Introduction
8.3.5 Bristol-Myers Squibb Recent Development
8.4 GSK
8.4.1 GSK Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Bipolar Disorder Therapeutics Drugs
8.4.4 Bipolar Disorder Therapeutics Drugs Product Introduction
8.4.5 GSK Recent Development
8.5 Janssen
8.5.1 Janssen Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Bipolar Disorder Therapeutics Drugs
8.5.4 Bipolar Disorder Therapeutics Drugs Product Introduction
8.5.5 Janssen Recent Development
8.6 AbbVie
8.6.1 AbbVie Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Bipolar Disorder Therapeutics Drugs
8.6.4 Bipolar Disorder Therapeutics Drugs Product Introduction
8.6.5 AbbVie Recent Development
8.7 Youdim
8.7.1 Youdim Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Bipolar Disorder Therapeutics Drugs
8.7.4 Bipolar Disorder Therapeutics Drugs Product Introduction
8.7.5 Youdim Recent Development
8.8 Delpor
8.8.1 Delpor Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Bipolar Disorder Therapeutics Drugs
8.8.4 Bipolar Disorder Therapeutics Drugs Product Introduction
8.8.5 Delpor Recent Development
8.9 Lundbeck
8.9.1 Lundbeck Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Bipolar Disorder Therapeutics Drugs
8.9.4 Bipolar Disorder Therapeutics Drugs Product Introduction
8.9.5 Lundbeck Recent Development
8.10 Intra-Cellular Therapies
8.10.1 Intra-Cellular Therapies Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Bipolar Disorder Therapeutics Drugs
8.10.4 Bipolar Disorder Therapeutics Drugs Product Introduction
8.10.5 Intra-Cellular Therapies Recent Development
8.11 Novartis Pharmaceuticals Corporation
8.12 Noven Pharmaceuticals
8.13 Otsuka
8.14 Pfizer
8.15 Reviva Pharmaceuticals
9 Market Forecast: Production Side
9.1 Production and Production Value Forecast
9.1.1 Global Bipolar Disorder Therapeutics Drugs Capacity, Production Forecast 2019-2025
9.1.2 Global Bipolar Disorder Therapeutics Drugs Production Value Forecast 2019-2025
9.2 Bipolar Disorder Therapeutics Drugs Production and Production Value Forecast by Regions
9.2.1 Global Bipolar Disorder Therapeutics Drugs Production Value Forecast by Regions
9.2.2 Global Bipolar Disorder Therapeutics Drugs Production Forecast by Regions
9.3 Bipolar Disorder Therapeutics Drugs Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.3.5 Other Regions
9.4 Forecast by Type
9.4.1 Global Bipolar Disorder Therapeutics Drugs Production Forecast by Type
9.4.2 Global Bipolar Disorder Therapeutics Drugs Production Value Forecast by Type
10 Market Forecast: Consumption Side
10.1 Consumption Forecast by Application
10.2 Bipolar Disorder Therapeutics Drugs Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Bipolar Disorder Therapeutics Drugs Consumption Forecast by Countries 2019-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Bipolar Disorder Therapeutics Drugs Consumption Forecast by Countries 2019-2025
10.4.2 France
10.4.3 UK
10.4.4 Italy
10.4.5 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption Forecast by Regions 2019-2025
10.5.2 Japan
10.5.3 South Korea
10.5.4 India
10.5.5 Australia
10.5.6 Indonesia
10.5.7 Thailand
10.5.8 Malaysia
10.5.9 Philippines
10.5.10 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Bipolar Disorder Therapeutics Drugs Consumption Forecast by Country 2019-2025
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption Forecast by Countries 2019-2025
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Bipolar Disorder Therapeutics Drugs Sales Channels
11.2.2 Bipolar Disorder Therapeutics Drugs Distributors
11.3 Bipolar Disorder Therapeutics Drugs Customers
12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis
13 Key Findings
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Figure Bipolar Disorder Therapeutics Drugs Product Picture
Table Bipolar Disorder Therapeutics Drugs Key Market Segments
Table Major Manufacturers Bipolar Disorder Therapeutics Drugs Covered in This Report
Table Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Bipolar Disorder Therapeutics Drugs Sales Market Shar by Type 2014-2025
Figure Olanzapine (Zyprexa) Figures
Table Major Manufacturers of Olanzapine (Zyprexa)
Figure Quetiapine (Seroquel) Figures
Table Major Manufacturers of Quetiapine (Seroquel)
Figure Risperidone (Risperdal) Figures
Table Major Manufacturers of Risperidone (Risperdal)
Figure Ariprazole (Abilify) Figures
Table Major Manufacturers of Ariprazole (Abilify)
Figure Ziprasidone (Geodon) Figures
Table Major Manufacturers of Ziprasidone (Geodon)
Figure Clozapine (Clozaril) Figures
Table Major Manufacturers of Clozapine (Clozaril)
Table Global Bipolar Disorder Therapeutics Drugs Market Share by Application 2019-2025 (K Units)
Figure lumateperone Use Case
Figure Central Nervous System (CNS) Disorders Use Case
Figure Bipolar Disorder Therapeutics Drugs Report Years Considered
Figure Global Bipolar Disorder Therapeutics Drugs Production Value Growth Rate 2014-2025 (Million US$)
Figure Global Bipolar Disorder Therapeutics Drugs Production 2014-2025 (K Units)
Figure Global Bipolar Disorder Therapeutics Drugs Capacity 2014-2025 (K Units)
Table Key Manufacturers Bipolar Disorder Therapeutics Drugs Capacity (K Units)
Figure Global Bipolar Disorder Therapeutics Drugs Price 2014-2025 (USD/Unit)
Table Global Bipolar Disorder Therapeutics Drugs Market Size of Key Regions (Million USD) & (K Units)
Table Global Bipolar Disorder Therapeutics Drugs Growth Rate of Key Regions 2019-2025 (Million USD)
Table Global Bipolar Disorder Therapeutics Drugs Market Share for of Regions 2019-2025 (K Units)
Table Market Top Trends
Table Global Bipolar Disorder Therapeutics Drugs Capacity by Manufacturers (2014-2019) (K Units)
Table Global Bipolar Disorder Therapeutics Drugs Capacity Market Share by Manufacturers (2014-2019)
Table Global Bipolar Disorder Therapeutics Drugs Production by Manufacturers (2014-2019) (K Units)
Table Global Bipolar Disorder Therapeutics Drugs Production Share by Manufacturers (2014-2019)
Figure Global Bipolar Disorder Therapeutics Drugs Production Share by Manufacturers in 2018
Table Bipolar Disorder Therapeutics Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Bipolar Disorder Therapeutics Drugs Revenue Share by Manufacturers (2014-2019)
Figure Bipolar Disorder Therapeutics Drugs Value Share by Manufacturers in 2018
Table Global Bipolar Disorder Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Bipolar Disorder Therapeutics Drugs Price by Manufacturers 2014-2019 (USD/Unit)
Table Key Manufacturers Bipolar Disorder Therapeutics Drugs Plants/Factories Distribution
Table Key Manufacturers Bipolar Disorder Therapeutics Drugs Area Served
Table Date of Key Manufacturers Enter into Bipolar Disorder Therapeutics Drugs Market
Table Key Manufacturers Bipolar Disorder Therapeutics Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Olanzapine (Zyprexa) Production and Production Value (2014-2019) (K Units) & (Million US$)
Table Global Quetiapine (Seroquel) Production and Production Value (2014-2019) (K Units) & (Million US$)
Table Global Risperidone (Risperdal) Production and Production Value (2014-2019) (K Units) & (Million US$)
Table Global Ariprazole (Abilify) Production and Production Value (2014-2019) (K Units) & (Million US$)
Table Global Ziprasidone (Geodon) Production and Production Value (2014-2019) (K Units) & (Million US$)
Table Global Clozapine (Clozaril) Production and Production Value (2014-2019) (K Units) & (Million US$)
Table Global Bipolar Disorder Therapeutics Drugs Production by Type (2014-2019) (K Units)
Table Global Bipolar Disorder Therapeutics Drugs Production Share by Type (2014-2019)
Figure Global Bipolar Disorder Therapeutics Drugs Production Market Share by Type (2014-2019)
Figure Global Bipolar Disorder Therapeutics Drugs Production Market Share by Type in 2018
Table Global Bipolar Disorder Therapeutics Drugs Production Value by Type (2014-2019) (Million US$)
Table Global Bipolar Disorder Therapeutics Drugs Production Value Share by Type (2014-2019)
Figure Global Bipolar Disorder Therapeutics Drugs Production Value Market Share by Type (2014-2019)
Figure Global Bipolar Disorder Therapeutics Drugs Production Value Market Share by Type in 2018
Table Bipolar Disorder Therapeutics Drugs Ex-factory Price by Type 2014-2019 (USD/Unit)
Table Global Bipolar Disorder Therapeutics Drugs Consumption by Application (2014-2019) (K Units)
Table Global Bipolar Disorder Therapeutics Drugs Consumption Share by Application (2014-2019)
Figure Global Consumption Bipolar Disorder Therapeutics Drugs Market Share by Application (2014-2019)
Table Global Bipolar Disorder Therapeutics Drugs Production by Regions 2014-2019 (K Units)
Table Global Bipolar Disorder Therapeutics Drugs Production Market Share by Regions 2014-2019
Figure Global Bipolar Disorder Therapeutics Drugs Production Market Share by Regions 2014-2019
Figure Global Bipolar Disorder Therapeutics Drugs Production Market Share by Regions in 2018
Table Global Bipolar Disorder Therapeutics Drugs Production Value by Regions 2014-2019 (Million USD)
Table Global Bipolar Disorder Therapeutics Drugs Production Value Market Share by Regions 2014-2019
Figure Global Bipolar Disorder Therapeutics Drugs Production Value Market Share by Regions 2014-2019
Figure Global Bipolar Disorder Therapeutics Drugs Production Value Market Share by Regions in 2018
Table United States Bipolar Disorder Therapeutics Drugs Production and Value 2014-2019 (K Units) & (Million USD)
Figure United States Bipolar Disorder Therapeutics Drugs Production Growth Rate 2014-2019 (K Units)
Figure United States Bipolar Disorder Therapeutics Drugs Production Value Growth Rate 2014-2019 (Million USD)
Table United States Bipolar Disorder Therapeutics Drugs Import & Export (K Units)
Table Europe Bipolar Disorder Therapeutics Drugs Production and Value 2014-2019 (K Units) & (Million USD)
Figure Europe Bipolar Disorder Therapeutics Drugs Production Growth Rate 2014-2019 (K Units)
Figure Europe Bipolar Disorder Therapeutics Drugs Production Value Growth Rate 2014-2019 (Million USD)
Table Europe Bipolar Disorder Therapeutics Drugs Import & Export (K Units)
Table China Bipolar Disorder Therapeutics Drugs Production and Value 2014-2019 (K Units) & (Million USD)
Figure China Bipolar Disorder Therapeutics Drugs Production Growth Rate 2014-2019 (K Units)
Figure China Bipolar Disorder Therapeutics Drugs Production Value Growth Rate 2014-2019 (Million USD)
Table China Bipolar Disorder Therapeutics Drugs Import & Export (K Units)
Table Japan Bipolar Disorder Therapeutics Drugs Production and Value 2014-2019 (K Units) & (Million USD)
Figure Japan Bipolar Disorder Therapeutics Drugs Production Growth Rate 2014-2019 (K Units)
Figure Japan Bipolar Disorder Therapeutics Drugs Production Value Growth Rate 2014-2019 (Million USD)
Table Japan Bipolar Disorder Therapeutics Drugs Import & Export (K Units)
Table Global Bipolar Disorder Therapeutics Drugs Consumption by Regions 2014-2019 (K Units)
Table Global Bipolar Disorder Therapeutics Drugs Consumption Market Share by Regions 2014-2019
Figure Global Bipolar Disorder Therapeutics Drugs Consumption Market Share by Regions 2014-2019
Figure Global Bipolar Disorder Therapeutics Drugs Consumption Market Share by Regions in 2018
Figure North America Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Table North America Bipolar Disorder Therapeutics Drugs Consumption by Type (2014-2019) (K Units)
Figure North America Bipolar Disorder Therapeutics Drugs Consumption Market Share by Type in 2018
Table North America Bipolar Disorder Therapeutics Drugs Consumption by Application (2014-2019) (K Units)
Figure North America Bipolar Disorder Therapeutics Drugs Consumption Market Share by Application in 2018
Table North America Bipolar Disorder Therapeutics Drugs Consumption by Countries (2014-2019) (K Units)
Figure North America Bipolar Disorder Therapeutics Drugs Consumption Market Share by Countries in 2018
Figure United States Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Canada Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Mexico Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Europe Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Table Europe Bipolar Disorder Therapeutics Drugs Consumption by Type (2014-2019) (K Units)
Figure Europe Bipolar Disorder Therapeutics Drugs Consumption Market Share by Type in 2018
Table Europe Bipolar Disorder Therapeutics Drugs Consumption by Application (2014-2019) (K Units)
Figure Europe Bipolar Disorder Therapeutics Drugs Consumption Market Share by Application in 2018
Table Europe Bipolar Disorder Therapeutics Drugs Consumption by Countries (2014-2019) (K Units)
Figure Europe Bipolar Disorder Therapeutics Drugs Consumption Market Share by Countries in 2018
Figure Germany Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure France Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure UK Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Italy Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Russia Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Table Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption by Type (2014-2019) (K Units)
Figure Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption Market Share by Type in 2018
Table Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption by Application (2014-2019) (K Units)
Figure Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption Market Share by Application in 2018
Table Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption by Regions (2014-2019) (K Units)
Table Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption Market Share by Countries (2014-2019)
Figure China Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Japan Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure South Korea Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure India Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Australia Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Indonesia Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Thailand Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Malaysia Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Philippines Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Vietnam Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Central & South America Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Table Central & South America Bipolar Disorder Therapeutics Drugs Consumption by Type (2014-2019) (K Units)
Figure Central & South America Bipolar Disorder Therapeutics Drugs Consumption Market Share by Type in 2018
Table Central & South America Bipolar Disorder Therapeutics Drugs Consumption by Application (2014-2019) (K Units)
Figure Central & South America Bipolar Disorder Therapeutics Drugs Consumption Market Share by Application in 2018
Table Central & South America Bipolar Disorder Therapeutics Drugs Consumption by Countries (2014-2019) (K Units)
Figure Central & South America Bipolar Disorder Therapeutics Drugs Consumption Market Share by Countries
Figure Brazil Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Table Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption by Type (2014-2019) (K Units)
Figure Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption Market Share by Type in 2018
Table Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption by Application (2014-2019) (K Units)
Figure Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption Market Share by Application in 2018
Figure Turkey Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure GCC Countries Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure Egypt Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Figure South Africa Bipolar Disorder Therapeutics Drugs Consumption Growth Rate (2014-2019) (K Units)
Table AstraZeneca Company Details
Table AstraZeneca Description and Business Overview
Table AstraZeneca Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Bipolar Disorder Therapeutics Drugs Production Growth Rate (2014-2019)
Table AstraZeneca Bipolar Disorder Therapeutics Drugs Production Market Share in Global Market
Table AstraZeneca Recent Development
Table Allergan Company Details
Table Allergan Description and Business Overview
Table Allergan Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan Bipolar Disorder Therapeutics Drugs Production Growth Rate (2014-2019)
Table Allergan Bipolar Disorder Therapeutics Drugs Production Market Share in Global Market
Table Allergan Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Description and Business Overview
Table Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Production Market Share in Global Market
Table Bristol-Myers Squibb Recent Development
Table GSK Company Details
Table GSK Description and Business Overview
Table GSK Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Bipolar Disorder Therapeutics Drugs Production Growth Rate (2014-2019)
Table GSK Bipolar Disorder Therapeutics Drugs Production Market Share in Global Market
Table GSK Recent Development
Table Janssen Company Details
Table Janssen Description and Business Overview
Table Janssen Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Janssen Bipolar Disorder Therapeutics Drugs Production Growth Rate (2014-2019)
Table Janssen Bipolar Disorder Therapeutics Drugs Production Market Share in Global Market
Table Janssen Recent Development
Table AbbVie Company Details
Table AbbVie Description and Business Overview
Table AbbVie Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Bipolar Disorder Therapeutics Drugs Production Growth Rate (2014-2019)
Table AbbVie Bipolar Disorder Therapeutics Drugs Production Market Share in Global Market
Table AbbVie Recent Development
Table Youdim Company Details
Table Youdim Description and Business Overview
Table Youdim Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Youdim Bipolar Disorder Therapeutics Drugs Production Growth Rate (2014-2019)
Table Youdim Bipolar Disorder Therapeutics Drugs Production Market Share in Global Market
Table Youdim Recent Development
Table Delpor Company Details
Table Delpor Description and Business Overview
Table Delpor Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Delpor Recent Development
Table Delpor Bipolar Disorder Therapeutics Drugs Production Growth Rate (2014-2019)
Table Delpor Bipolar Disorder Therapeutics Drugs Production Market Share in Global Market
Table Lundbeck Company Details
Table Lundbeck Description and Business Overview
Table Lundbeck Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Lundbeck Bipolar Disorder Therapeutics Drugs Production Growth Rate (2014-2019)
Table Lundbeck Bipolar Disorder Therapeutics Drugs Production Market Share in Global Market
Table Lundbeck Recent Development
Table Intra-Cellular Therapies Company Details
Table Intra-Cellular Therapies Description and Business Overview
Table Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Production Growth Rate (2014-2019)
Table Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Production Market Share in Global Market
Table Intra-Cellular Therapies Recent Development
Table Novartis Pharmaceuticals Corporation Company Details
Table Noven Pharmaceuticals Company Details
Table Otsuka Company Details
Table Pfizer Company Details
Table Reviva Pharmaceuticals Company Details
Table Global Bipolar Disorder Therapeutics Drugs Capacity, Production Forecast 2019-2025 (K Units)
Figure Global Bipolar Disorder Therapeutics Drugs Capacity Forecast 2019-2025 (K Units)
Figure Global Bipolar Disorder Therapeutics Drugs Production Forecast 2019-2025 (K Units)
Figure Global Bipolar Disorder Therapeutics Drugs Production Value Forecast 2019-2025 (Million US$)
Table Global Bipolar Disorder Therapeutics Drugs Revenue Forecast 2019-2025 (Million US$)
Table Global Bipolar Disorder Therapeutics Drugs Production Value Forecast by Regions 2019-2025 (Million US$)
Figure Global Bipolar Disorder Therapeutics Drugs Production Value Forecast by Regions 2019-2025 (Million US$)
Figure Global Bipolar Disorder Therapeutics Drugs Production Value Market Share Forecast by Regions 2019-2025
Table Global Bipolar Disorder Therapeutics Drugs Production Forecast by Regions 2019-2025 (K Units)
Figure Global Bipolar Disorder Therapeutics Drugs Production Forecast by Regions 2019-2025 (K Units)
Figure Global Bipolar Disorder Therapeutics Drugs Production Market Share Forecast by Regions 2019-2025
Table United States Bipolar Disorder Therapeutics Drugs Production and Value Forecast 2019-2025 (K Units) & (Million US$)
Figure United States Bipolar Disorder Therapeutics Drugs Production Forecast 2019-2025 (K Units)
Figure United States Bipolar Disorder Therapeutics Drugs Revenue Forecast 2019-2025 (Million US$)
Table Europe Bipolar Disorder Therapeutics Drugs Production and Value Forecast 2019-2025 (K Units) & (Million US$)
Figure Europe Bipolar Disorder Therapeutics Drugs Production Forecast 2019-2025 (K Units)
Figure Europe Bipolar Disorder Therapeutics Drugs Revenue Forecast 2019-2025 (Million US$)
Table China Bipolar Disorder Therapeutics Drugs Production and Value Forecast 2019-2025 (K Units) & (Million US$)
Figure China Bipolar Disorder Therapeutics Drugs Production Forecast 2019-2025 (K Units)
Figure China Bipolar Disorder Therapeutics Drugs Revenue Forecast 2019-2025 (Million US$)
Table Japan Bipolar Disorder Therapeutics Drugs Production and Value Forecast 2019-2025 (K Units) & (Million US$)
Figure Japan Bipolar Disorder Therapeutics Drugs Production Forecast 2019-2025 (K Units)
Figure Japan Bipolar Disorder Therapeutics Drugs Revenue Forecast 2019-2025 (Million US$)
Table Global Bipolar Disorder Therapeutics Drugs Production Forecast by Type 2019-2025 (K Units)
Figure Global Bipolar Disorder Therapeutics Drugs Production Forecast by Type 2019-2025 (K Units)
Figure Global Bipolar Disorder Therapeutics Drugs Production Market Share Forecast by Type 2019-2025
Table Global Bipolar Disorder Therapeutics Drugs Production Value Forecast by Type 2019-2025 (Million US$)
Figure Global Bipolar Disorder Therapeutics Drugs Production Value Forecast by Type 2019-2025 (Million US$)
Figure Global Bipolar Disorder Therapeutics Drugs Production Value Market Share Forecast by Type 2019-2025
Table Global Bipolar Disorder Therapeutics Drugs Consumption Forecast by Application 2019-2025 (K Units)
Figure Global Bipolar Disorder Therapeutics Drugs Consumption Forecast by Application 2019-2025 (K Units)
Figure Global Bipolar Disorder Therapeutics Drugs Consumption Market Share Forecast by Application 2019-2025
Table Global Bipolar Disorder Therapeutics Drugs Consumption Forecast by Regions 2019-2025 (K Units)
Figure Global Bipolar Disorder Therapeutics Drugs Consumption Forecast by Regions 2019-2025 (K Units)
Figure Global Bipolar Disorder Therapeutics Drugs Consumption Market Share Forecast by Regions 2019-2025
Table North America Bipolar Disorder Therapeutics Drugs Consumption Forecast by Regions 2019-2025 (K Units)
Figure United States Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure Canada Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure Mexico Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Table Europe Bipolar Disorder Therapeutics Drugs Consumption Forecast by Regions 2019-2025 (K Units)
Figure Germany Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure France Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure UK Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure Italy Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure Russia Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Table Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption Forecast by Regions 2019-2025 (K Units)
Figure China Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure Japan Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure South Korea Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure India Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure Australia Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure Indonesia Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure Thailand Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure Malaysia Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure Philippines Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure Vietnam Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Table Central & South America Bipolar Disorder Therapeutics Drugs Consumption Forecast by Regions 2019-2025 (K Units)
Figure Brazil Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Table Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption Forecast by Regions 2019-2025 (K Units)
Figure Turkey Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure GCC Countries Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure Egypt Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure South Africa Bipolar Disorder Therapeutics Drugs Consumption Forecast 2019-2025 (K Units)
Figure Bipolar Disorder Therapeutics Drugs Value Chain
Table Bipolar Disorder Therapeutics Drugs Distributors List
Table Bipolar Disorder Therapeutics Drugs Customers List
Table Porter's Five Forces Analysis
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
双極性障害治療法の世界市場：市場規模・現状・予測 Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood.The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics. In 2018, the global Bipolar Disorder Therapeu…- 双極性障害の世界市場：市場規模・現状・予測 Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. There are four basic types of bipolar disorder; all of them involve clear changes in mood, energy, and activity le…
- 自閉症スペクトラム障害診断及び治療の世界市場：市場規模・現状・予測 Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Over the past few years, with the increased number of infants an…
- 胃腸障害治療薬の世界市場：市場規模・現状・予測 Gastrointestinal disorder is mainly associated with the impairment of gastrointestinal functions that are affected mainly by contaminated or poisonous food. Gastrointestinal disorders includes irritable bowel syndrome, gastroesophageal reflux diseases and peptic ulcer diseases.Increasing incidences …
- 世界の季節性情動障害治療薬市場：専門的調査 Seasonal affective disorder or SAD is a recurrent major depressive disorder with a seasonal pattern usually beginning in fall and continuing into winter months. The global Seasonal Affective Disorder Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, …